Inventor · disambiguated record
Shay Soker
Also filed as: SOKER SHAY
25 granted patents·14 pending applications·310 citations·filing 2000–2023
96Inventor score
Files withCHILDRENS MEDICAL CENTER11UNIV WAKE FOREST HEALTH SCIENCES11ATALA ANTHONY6KLAGSBRUN MICHAEL3CHILDEN S MEDICAL CT CORP1
Top patents by PatentIndex Score
39 records- 0196US7531503B2Cell scaffold matrices with incorporated therapeutic agentsUNIV WAKE FOREST HEALTH SCIENCES·Filed 2005·Granted May 12, 2009·76 cites·16 claims
- 0296US6777534B1Peptide antagonists of vascular endothelial growth factorCHILDRENS MEDICAL CENTER·Filed 2000·Granted Aug 17, 2004·84 cites·4 claims
- 0393US9163331B2Electrospun cell matricesATALA ANTHONY·Filed 2009·Granted Oct 20, 2015·18 cites·18 claims
- 0493US7335357B2Antagonists of neuropilin receptor function and use thereofCHILDRENS MEDICAL CENTER·Filed 2006·Granted Feb 26, 2008·13 cites·5 claims
- 0587US9938502B2Tissue-specific extracellular matrix with or without tissue protein components for cell cultureZHANG YUANYUAN·Filed 2011·Granted Apr 10, 2018·7 cites·54 claims
- 0686US6635421B1Neuropilins and use thereof in methods for diagnosis and prognosis of cancerCHILDRENS MEDICAL CENTER·Filed 2000·Granted Oct 21, 2003·23 cites·4 claims
- 0785US7736655B2Soluble inhibitors of vascular endothelial growth factor and use thereofCHILDRENS MEDICAL CENTER·Filed 2007·Granted Jun 15, 2010·6 cites·7 claims
- 0883US9056093B2Regeneration of pancreatic islets by amniotic fluid stem cell therapyATALA ANTHONY·Filed 2006·Granted Jun 16, 2015·8 cites·32 claims
- 0983US8491457B2Tissue engineered blood vesselsATALA ANTHONY·Filed 2006·Granted Jul 23, 2013·29 cites·23 claims
- 1081US7883847B2Transcriptional profiling of stem cells and their multilineage differentiationUNIV WAKE FOREST HEALTH SCIENCES·Filed 2006·Granted Feb 8, 2011·2 cites·7 claims
- 1180US8529905B2Soluble inhibitors of vascular endothelial growth factor and use thereofKLAGSBRUN MICHAEL·Filed 2010·Granted Sep 10, 2013·4 cites·4 claims
- 1279US11648335B2Organ/tissue decellularization, framework maintenance and recellularizationUNIV WAKE FOREST HEALTH SCIENCES·Filed 2015·Granted May 16, 2023·3 cites·17 claims
- 1379US7731959B2Antagonists of neuropilin receptor function and use thereofCHILDRENS MEDICAL CENTER·Filed 2002·Granted Jun 8, 2010·3 cites·1 claims
- 1479US7273612B2Soluble inhibitors of vascular endothelial growth factor and use thereofCHILDRENS MEDICAL CENTER·Filed 2002·Granted Sep 25, 2007·8 cites·2 claims
- 1579US2023417740A1Tissue-mimicking hydrogel compositions for biofabricationUNIV WAKE FOREST HEALTH SCIENCES·Filed 2023·Application pending·0 cites
- 1678US8940292B2Enhancement of angiogenesis to grafts using cells engineered to produce growth factorsATALA ANTHONY·Filed 2004·Granted Jan 27, 2015·7 cites·27 claims
- 1775US9062346B2Transcriptional profiling of stem cells and their multilineage differentiationHIPP JASON·Filed 2010·Granted Jun 23, 2015·2 cites·17 claims
- 1874US8153585B2Peptide antagonists of vascular endothelial growth factor and methods of use thereofKLAGSBRUN MICHAEL·Filed 2008·Granted Apr 10, 2012·1 cites·4 claims
- 1973US10052350B2Fabrication of gelatin hydrogel sheet for the transplantation of corneal endotheliumUNIV WAKE FOREST HEALTH SCIENCES·Filed 2012·Granted Aug 21, 2018·5 cites·12 claims
- 2072US7666393B2Methods for assessing antiangiogenic agentsCHILDRENS MEDICAL CENTER·Filed 2002·Granted Feb 23, 2010·3 cites·8 claims
- 2171US12337078B2Organ/tissue decellularization, framework maintenance and recellularizationUNIV WAKE FOREST HEALTH SCIENCES·Filed 2023·Granted Jun 24, 2025·0 cites·9 claims
- 2271US8889620B2Pharmaceutical compositions comprising peptide antagonists of vascular endothelial growth factorKLAGSBRUN MICHAEL·Filed 2012·Granted Nov 18, 2014·1 cites·3 claims
- 2370US7414027B2Peptide antagonists of vascular endothelial growth factorCHILDEN S MEDICAL CT CORP·Filed 2004·Granted Aug 19, 2008·5 cites·6 claims
- 2466US2015025224A1Antagonists of neuropilin receptor function and use thereofCHILDRENS MEDICAL CENTER·Filed 2014·Application pending·0 cites
- 2565US2008076906A1Antagonists of neuropilin receptor function and use thereofCHILDRENS MEDICAL CENTER·Filed 2007·Application pending·0 cites
- 2661US2014056872A1Antagonists of neuropilin receptor function and use thereofCHILDRENS MEDICAL CENTER·Filed 2012·Application pending·0 cites
- 2760US8628572B2Corneal endothelial scaffolds and methods of useSOKER SHAY·Filed 2010·Granted Jan 14, 2014·2 cites·15 claims
- 2859US2014178986A1Soluble inhibitors of vascular endothelial growth factor and use thereofCHILDRENS MEDICAL CENTER·Filed 2013·Application pending·0 cites
- 2957US2011002919A1Antagonists of neuropilin receptor function and use thereofCHILDREN S MEDICAL CT·Filed 2010·Application pending·0 cites
- 3054US9707256B2Methods of making endothelial scaffoldsUNIV WAKE FOREST HEALTH SCIENCES·Filed 2013·Granted Jul 18, 2017·0 cites·10 claims
- 3154US2015247194A1Transcriptional profiling of stem cells and their multilineage differentiationUNIV WAKE FOREST HEALTH SCIENCES·Filed 2015·Application pending·0 cites
- 3253US2005203013A1Methods for inhibiting vascular permeabilityFiled 2004·Application pending·0 cites
- 3349US2006204539A1Electrospun cell matricesATALA ANTHONY·Filed 2005·Application pending·0 cites
- 3449US2017307598A1Tissue-mimicking hydrogel compositions for biofabricationUNIV WAKE FOREST HEALTH SCIENCES·Filed 2015·Application pending·0 cites
- 3548US2005112063A1Methods for inhibiting vascular permeabilityFiled 2004·Application pending·0 cites
- 3646US2006204445A1Cell scaffold matrices with image contrast agentsATALA ANTHONY·Filed 2005·Application pending·0 cites
- 3741US10913933B2Bioengineered liver constructs and methods relating theretoUNIV WAKE FOREST HEALTH SCIENCES·Filed 2014·Granted Feb 9, 2021·0 cites·20 claims
- 3840US2020377863A1Model system of liver fibrosis and method of making and using the sameUNIV WAKE FOREST HEALTH SCIENCES·Filed 2017·Application pending·0 cites
- 3939US2010273167A1Methods for determining prenatal alcohol exposureHIPP JENNIFER·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →